Glp 1 Agonists Side Effects

A jama article meta analysis in 2018 covering studies concerning glp 1 agonists dpp 4 inhibitors and sglt2 inhibitors showed glp 1 agonists were associated with lower stroke risk than controls.

Glp 1 agonists side effects.

Possible side effects of incretin mimetics include. Increasing insulin secretion from the pancreas after a meal. You need inject incretin mimetics also known as glp 1 agonists under your skin just before a meal. Side effects from long term use of glp 1s have been an area of concern.

Although rare these side effects should be treated as an emergency. Since these drugs are relatively new there are limited studies to evaluate the claims of glp 1 induced pancreatitis. Some side effects are warning signs of serious conditions. Nausea vomiting and diarrhea can occur in many people.

For example nausea and vomiting with abdominal pain could be pancreatitis inflammation of the pancreas. Nausea may improve with time and a lower dose. While pancreatitis by itself is not a major concern chronic pancreatitis is linked to an increase in the risk for pancreatic cancer. Feelings of early fullness lower appetite nausea vomiting diarrhea.

Other common adverse effects include injection site reactions headache and nasopharyngitis but these effects do not usually result in discontinuation of the drug. Glp 1 receptor agonists can cause nausea vomiting diarrhea headache weakness or dizziness. Diarrhoea nausea vomiting headaches dizziness increased sweating indigestion constipation loss of appetite. Some of the more common side effects include.

Also it may occur less often with the. Side effects of incretin mimetics or glp 1 drugs may be the result of the way they work in the human body. 3 ongoing pain in the upper left or middle of the stomach that may spread to the back with or without vomiting a skin rash or hives itching pounding heart dizziness or fainting swelling of the eyes face mouth tongue throat. The most common symptoms associated with the use of glp 1 receptor agonists are gastrointestinal symptoms mainly nausea.